Reported 47,000 shares, down 10,000 (17.5%) from the prior quarter.
Reported value 1.2%; share count -17.5% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-09-30 | 3905372 |
| 2025-12-31 | 585960 |
| 2026-03-31 | 593140 |
| 2026-06-30 | 441600 |
| 2026-09-30 | 381000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 60,000 | 0 (0.0%) | < 0.01% | $381,000 | 2026-11-16 | |
| Q2 2026 | Added | 60,000 | +13,000 (27.7%) | < 0.01% | $441,600 | 2026-08-14 | |
| Q1 2026 | Reduced | 47,000 | -10,000 (-17.5%) | < 0.01% | $593,140 | 2026-05-15 | |
| Q4 2025 | Reduced | 57,000 | -10,334 (-15.3%) | < 0.01% | $585,960 | 2026-02-17 | |
| Q3 2025 | New | 67,334 | +67,334 (0.0%) | 0.04% | $3,905,372 | 2025-11-14 |
Who else reported the position
131 managers reported ENTRADA THERAPEUTICS INC for Q1 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BAKER BROS ADVISORS LP | Unchanged | 5,072,730 | 0 | 0.37% | $64,017,853 | 18 qtrs |
| 5AM Venture Management LLC | Unchanged | 4,056,379 | 0 | 14.21% | $51,191,503 | 18 qtrs |
| BlackRock Inc | Added | 2,358,793 | +211,533 | < 0.01% | $29,767,968 | 7 qtrs |
| TCG Crossover Management LLC | Added | 2,287,500 | +199,108 | 0.83% | $28,868,250 | 18 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | New | 1,256,013 | +1,256,013 | < 0.01% | $15,850,884 | 1 qtr |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1,034,782 | -9,976 | < 0.01% | $13,058,949 | 18 qtrs |
| StepStone Group LP | Unchanged | 761,277 | 0 | 4.63% | $9,607,316 | 18 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 667,347 | +27,400 | < 0.01% | $8,423,655 | 18 qtrs |
| STATE STREET CORPORATION | Added | 533,798 | +25,009 | < 0.01% | $6,736,531 | 18 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 526,043 | +198,620 | < 0.01% | $6,639,000 | 18 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2026
- Filed
- May 15, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 47,000
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.